NCT06927089

Brief Summary

Non-invasive hemodynamic monitoring of interstitial lung disease (ILD) patients admitted to respiratory ICU with acute respiratory failure and differentiate according to different modes of mechanical ventilation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2024

Completed
6 months until next milestone

First Posted

Study publicly available on registry

April 15, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

August 16, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

April 15, 2025

Status Verified

February 1, 2025

Enrollment Period

4 months

First QC Date

October 25, 2024

Last Update Submit

April 13, 2025

Conditions

Interstitial Lung Disease (ILD)

Keywords

ILDMVnon-invasive hemodynamic monitoring

Outcome Measures

Primary Outcomes (1)

  • Non-invasive Hemodynamic Monitoring

    1 hour

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Interstitial lung disease patients with acute respiratory failure admitted to respiratory ICU in different modes of MV (NIV, invasive MV and HVNI).

You may qualify if:

  • Interstitial lung disease patients with acute respiratory failure admitted to respiratory ICU in different modes of MV (NIV, invasive MV and HVNI).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, Asyut Governorate, 71515, Egypt

Location

MeSH Terms

Conditions

Lung Diseases, Interstitial

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Central Study Contacts

Safaa Abdelgayed Eid

CONTACT

+20 01002569966safaa_gayed@aun.edu.eg

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 25, 2024

First Posted

April 15, 2025

Study Start

August 16, 2025

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

April 15, 2025

Record last verified: 2025-02

Locations

EG(1)